Get the Stockscreener App
22.34
5.94%
-1.41
After Hours:
22.99
0.65
+2.91%
Structure Therapeutics Inc Adr Stock (GPCR) Latest News
Leerink cuts Structure Therapeutics target to $60, keeps outperform - Investing.com India
Structure Therapeutics (NASDAQ:GPCR) Research Coverage Started at William Blair - Defense World
Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World
Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $81.29 - Defense World
Structure Therapeutics (NASDAQ:GPCR) Coverage Initiated by Analysts at William Blair - MarketBeat
Structure Therapeutics Advances in Obesity Treatment Pipeline - TipRanks
Structure Therapeutics (NASDAQ:GPCR) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Shares Up 8% on Earnings Beat - MarketBeat
Structure Therapeutics, Inc.: Promising Outlook with Aleniglipron in Obesity Treatment and Strategic Advancements Justify Buy Rating - TipRanks
Promising Potential of Structure Therapeutics’ Aleniglipron: A Compelling Buy Recommendation - TipRanks
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $81.29 Average Price Target from Brokerages - MarketBeat
Buy Rating for Structure Therapeutics: Promising Phase 2b Trials and Strong Financial Position - TipRanks
Structure Therapeutics (NASDAQ:GPCR) Hits New 52-Week LowTime to Sell? - MarketBeat
Structure Therapeutics reports Q4 net loss $36.5M vs. net loss $24.5M last year - TipRanks
Structure Therapeutics (NASDAQ:GPCR) Trading Down 6.4%Time to Sell? - MarketBeat
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights - The Manila Times
Can Structure Therapeutics' Obesity Drug Challenge Wegovy? Trial Enrollment Complete - StockTitan
Handelsbanken Fonder AB Acquires Shares of 165,000 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
GPCR stock touches 52-week low at $20.11 amid market challenges By Investing.com - Investing.com South Africa
GPCR stock touches 52-week low at $20.11 amid market challenges - Investing.com India
Structure Therapeutics (NASDAQ:GPCR) Trading Up 6.2%Here's Why - MarketBeat
Structure Therapeutics Inc. (NASDAQ:GPCR) Sees Large Decline in Short Interest - MarketBeat
GPCR Stock Hits 52-Week Low at $23.48 Amid Market Challenges - Investing.com Canada
Structure Therapeutics (NASDAQ:GPCR) Sets New 52-Week Low – Here’s What Happened - Defense World
Why Structure Therapeutics Stock Was Stumbling This Week - The Globe and Mail
abrdn plc Sells 45,695 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Financial Fitness Check: Examining Structure Therapeutics Inc ADR (GPCR)’s Key Ratios - The Dwinnex
Spire Wealth Management Acquires Shares of 8,949 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Trading Down 6.7%Should You Sell? - MarketBeat
HSBC Securities Downgrades Morgan Stanley (MS) to a Hold from a Buy - Knox Daily
JD.com Inc ADR (JD) receives an Outperform rating from Bernstein - Knox Daily
Ratio Examination: Bausch Health Companies Inc (BHC)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Brokerages Set Structure Therapeutics Inc. (NASDAQ:GPCR) PT at $81.29 - MarketBeat
Understanding the Recent Fluctuations of Structure Therapeutics Inc ADR’s (GPCR) Stock - The News Heater
Structure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Update - MarketBeat
CCG Wealth Management LLC Makes New $4.07 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) PT at $81.29 - Defense World
GLP-1 Agonists Weight Loss Drugs Market Size Report, 2030 - Grand View Research
Short Interest in Structure Therapeutics Inc. (NASDAQ:GPCR) Rises By 5.8% - Defense World
Structure Therapeutics (NASDAQ:GPCR) Stock Price Up 8.3%Still a Buy? - MarketBeat
Structure Therapeutics Lines Up Triple Conference Appearances: What's Next for GPCR? - StockTitan
Fidelity Electric Vehicles and Future Transportation ETF (BATS:FDRV) Shares Up 0.5% – Still a Buy? - Defense World
Liberty TripAdvisor (NASDAQ:LTRPA) Now Covered by Analysts at StockNews.com - Defense World
ImmuPharma (LON:IMM) Trading 13.6% Higher – Here’s What Happened - Defense World
JPMorgan Chase & Co. Has $1.31 Million Stock Holdings in iShares International Treasury Bond ETF (NASDAQ:IGOV) - Defense World
JPMorgan Chase & Co. Grows Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Air T (NASDAQ:AIRT) Shares Cross Below 200-Day Moving Average – What’s Next? - Defense World
JPMorgan Chase & Co. Acquires 25,500 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):